FDA Inspection 1170172 — South Texas Blood And Tissue Center
The FDA completed an inspection of South Texas Blood And Tissue Center on May 3, 2022 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- San Antonio, TX (United States)